Your browser doesn't support javascript.
loading
Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population.
You, Liang-Zhen; Dai, Qian-Qian; Zhong, Xiao-Ying; Yu, Dong-Dong; Cui, He-Rong; Kong, Yi-Fan; Zhao, Meng-Zhu; Zhang, Xin-Yi; Xu, Qian-Qian; Guan, Zhi-Yue; Wei, Xu-Xu; Zhang, Xue-Cheng; Han, Song-Jie; Liu, Wen-Jing; Chen, Zhao; Zhang, Xiao-Yu; Zhao, Chen; Jin, Ying-Hui; Shang, Hong-Cai.
Affiliation
  • You LZ; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China; Key Laboratory of Internal Medicine of Chinese Medicine, Ministry of Education, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Dai QQ; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China; Key Laboratory of Internal Medicine of Chinese Medicine, Ministry of Education, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Zhong XY; School of Medical Information Engineering, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong Province, China.
  • Yu DD; The First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, Anhui Province, China.
  • Cui HR; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Kong YF; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Zhao MZ; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Zhang XY; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Xu QQ; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Guan ZY; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Wei XX; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Zhang XC; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Han SJ; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Liu WJ; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Chen Z; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China; Institute of Clinical Basic Medicine of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Zhang XY; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China; Institute of Clinical Basic Medicine of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Zhao C; Institute of Clinical Basic Medicine of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Jin YH; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
  • Shang HC; Dongzhimen Hospital Key Laboratory, Beijing University of Chinese Medicine, Beijing 100700, China; Key Laboratory of Internal Medicine of Chinese Medicine, Ministry of Education, Beijing University of Chinese Medicine, Beijing 100700, China. Electronic address: shanghongcai@126.com.
J Integr Med ; 21(5): 441-454, 2023 09.
Article in En | MEDLINE | ID: mdl-37596131

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Drugs, Chinese Herbal / COVID-19 / COVID-19 Drug Treatment / Medicine, Chinese Traditional Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: J Integr Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Drugs, Chinese Herbal / COVID-19 / COVID-19 Drug Treatment / Medicine, Chinese Traditional Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: J Integr Med Year: 2023 Document type: Article